{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:46:46Z","timestamp":1775911606925,"version":"3.50.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Proton pump inhibitors (PPIs) are commonly prescribed drugs in clinical practice, mainly for the treatment of <jats:italic toggle=\"yes\">Helicobacter pylori<\/jats:italic> infection and gastroesophageal reflux disease (GERD). With the application of PPIs, doctors have found a variety of adverse reactions related to it, with gastric cancer being the most serious. Our aim is to investigate whether the use of PPIs increases the probability of gastric cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>By searching PubMed, EMBASE, the Cochrane Library and Web of science, references related to PPIs and gastric cancer were selected, and Newcastle-Ottawa scale (NOS) was used to evaluate the quality of the included references and analyze their bias. Then stataSE-64 was used for statistical analysis. The above processes were independently searched and evaluated by 2 researchers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The use of PPIs significantly increased the incidence of gastric cancer (RR\u2005=\u20051.75, 95% CI: 1.48\u20132.07, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.000).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Long-term use of PPIs may increase the incidence of gastric cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000043053","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T18:02:03Z","timestamp":1752516123000},"page":"e43053","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A meta-analysis of the effects of proton pump inhibitors on the risk of gastric cancer"],"prefix":"10.1097","volume":"104","author":[{"given":"Hao","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Abdominal Surgery, The Second People\u2019s Hospital of Hengshui City, Hengshui City, Hebei Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianyu","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei Medical University Third Hospital, Shijiazhuang City, Hebei Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongyun","family":"Gou","sequence":"additional","affiliation":[{"name":"The Medical Record Room of the Medical Affairs Department, Hebei Medical University First Hospital, Shijiazhuang City, Hebei Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Mathematics and Computer Science, Hengshui University, Hengshui City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Hebei Medical University Third Hospital, Shijiazhuang City, Hebei Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyu","family":"Liu","sequence":"additional","affiliation":[{"name":"General Surgery Department, the Affiliated Hospital of Hebei University, Baoding City, Hebei Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei Medical University Third Hospital, Shijiazhuang City, Hebei Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2480-1790","authenticated-orcid":false,"given":"Hongyan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei Medical University Third Hospital, Shijiazhuang City, Hebei Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250812","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.292.16.1955","article-title":"Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.","volume":"292","author":"Laheij","year":"2004","journal-title":"JAMA"},{"key":"R2-20250812","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture.","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"R3-20250812","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","article-title":"Systematic review of the risk of enteric infection in patients taking acid suppression.","volume":"102","author":"Leonard","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R4-20250812","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid-suppressive agents and the risk of community-acquired clostridium difficile-associated disease.","volume":"294","author":"Dial","year":"2005","journal-title":"JAMA"},{"key":"R5-20250812","doi-asserted-by":"crossref","first-page":"d2690","DOI":"10.1136\/bmj.d2690","article-title":"Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study.","volume":"342","author":"Charlot","year":"2011","journal-title":"BMJ"},{"key":"R6-20250812","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease.","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"key":"R7-20250812","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis.","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"key":"R8-20250812","doi-asserted-by":"crossref","first-page":"646","DOI":"10.5009\/gnl20036","article-title":"Proton pump inhibitor-related gastric mucosal changes.","volume":"15","author":"Kim","year":"2021","journal-title":"Gut Liver"},{"key":"R9-20250812","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R10-20250812","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","article-title":"Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin.","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"},{"key":"R11-20250812","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41416-020-0860-4","article-title":"Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies.","volume":"123","author":"Liu","year":"2020","journal-title":"Br J Cancer"},{"key":"R12-20250812","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","article-title":"Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study.","volume":"67","author":"Cheung","year":"2018","journal-title":"Gut"},{"key":"R13-20250812","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/gutjnl-2021-325097","article-title":"Proton pump inhibitors and risk of gastric cancer: population-based cohort study.","volume":"71","author":"Abrahami","year":"2022","journal-title":"Gut"},{"key":"R14-20250812","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1136\/gutjnl-2017-315710","article-title":"Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis.","volume":"67","author":"Niikura","year":"2018","journal-title":"Gut"},{"key":"R15-20250812","doi-asserted-by":"crossref","first-page":"e000719","DOI":"10.1136\/bmjgast-2021-000719","article-title":"Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer.","volume":"8","author":"Ng","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"key":"R16-20250812","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1136\/gutjnl-2020-323845","article-title":"Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.","volume":"70","author":"Seo","year":"2021","journal-title":"Gut"},{"key":"R17-20250812","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/gutjnl-2018-316057","article-title":"Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD.","volume":"68","author":"Peng","year":"2019","journal-title":"Gut"},{"key":"R18-20250812","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2165\/00002018-200831080-00004","article-title":"Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.","volume":"31","author":"Tamim","year":"2008","journal-title":"Drug Saf"},{"key":"R19-20250812","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14309\/ajg.0000000000000591","article-title":"Proton pump inhibitor use and risk of gastric, colorectal, liver, and pancreatic cancers in a community-based population.","volume":"115","author":"Lee","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"R20-20250812","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2005.086579","article-title":"Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.","volume":"55","author":"Garc\u00eda Rodr\u00edguez","year":"2006","journal-title":"Gut"},{"key":"R21-20250812","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1158\/1055-9965.EPI-08-0764","article-title":"Antacid drug use and risk of esophageal and gastric adenocarcinomas in Los Angeles County.","volume":"18","author":"Duan","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R22-20250812","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/gutjnl-2018-316371","article-title":"Proton pump inhibitors and risk of gastric cancer in a case-control study.","volume":"68","author":"Lai","year":"2019","journal-title":"Gut"},{"key":"R23-20250812","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/gut.2010.207662","article-title":"Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori.","volume":"60","author":"Hagiwara","year":"2011","journal-title":"Gut"},{"key":"R24-20250812","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.gtc.2013.01.002","article-title":"Gastric cancer: overview.","volume":"42","author":"Correa","year":"2013","journal-title":"Gastroenterol Clin North Am"},{"key":"R25-20250812","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1349-7006.2010.01743.x","article-title":"Anthropological and clinical implications for the structural diversity of the Helicobacter pylori CagA oncoprotein.","volume":"102","author":"Hatakeyama","year":"2011","journal-title":"Cancer Sci"},{"key":"R26-20250812","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2217\/fon.14.29","article-title":"Helicobacter pylori virulence and cancer pathogenesis.","volume":"10","author":"Yamaoka","year":"2014","journal-title":"Future Oncol"},{"key":"R27-20250812","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12328-017-0714-7","article-title":"Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.","volume":"10","author":"Anjiki","year":"2017","journal-title":"Clin J Gastroenterol"},{"key":"R28-20250812","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/00365521.2018.1450442","article-title":"Proton pump inhibitors (PPIs) may cause gastric cancer \u2013 clinical consequences.","volume":"53","author":"Waldum","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"R29-20250812","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<435::AID-CNCR11>3.0.CO;2-X","article-title":"Neuroendocrine differentiation in human gastric carcinoma.","volume":"83","author":"Waldum","year":"1998","journal-title":"Cancer"},{"key":"R30-20250812","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1369\/jhc.5A6806.2005","article-title":"Signet ring cells in gastric carcinomas are derived from neuroendocrine cells.","volume":"54","author":"Bakkelund","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"R31-20250812","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0928-4257(00)00156-X","article-title":"Gastrin and pentagastrin enhance the tumour proliferation of human stable cultured gastric adenocarcinoma cells.","volume":"94","author":"Szab\u00f3","year":"2000","journal-title":"J Physiol Paris"},{"key":"R32-20250812","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/gut.47.6.820","article-title":"Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence.","volume":"47","author":"Smith","year":"2000","journal-title":"Gut"},{"key":"R33-20250812","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/CEJ.0000000000000008","article-title":"Gastrin: from pathophysiology to cancer prevention and treatment.","volume":"23","author":"Maddalo","year":"2014","journal-title":"Eur J Cancer Prev"},{"key":"R34-20250812","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.lungcan.2004.07.998","article-title":"Tobacco smoking and cancer: a brief review of recent epidemiological evidence.","volume":"45","author":"Sasco","year":"2004","journal-title":"Lung Cancer"},{"key":"R35-20250812","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","article-title":"Helicobacter pylori-induced gastric inflammation and gastric cancer.","volume":"345","author":"Wang","year":"2014","journal-title":"Cancer Lett"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:02:03Z","timestamp":1755018123000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":35,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043053","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}